Carbamazepine is metabolized in the liver to carbamazepine-10, 11-epoxide, which is the active metabolite the leads to pharmacological action.HLA-A*3101 and HLA-B*1502 genotypes should be conducted alongside a pregnancy test.

Clinicians should discontinue this drug at the first sign of a drug-related rash, any evidence of significant bone marrow depression, or worsening hepatic damage. Withdrawal should be gradual as immediate withdrawal severely increases the risk for status epilepticus. Abrupt discontinuation leads to severe hypoxia that can be fatal, especially to a pregnant woman. Even smaller seizures from withdrawing the drug too fast can lead to significant damage to the fetus.Â Routine screening should be ordered with a pregnant woman to assess for possible defects.